Author:
Mizuno Shohei,Hanamura Ichiro,Ota Akinobu,Karnan Sivasundaram,Narita Tomoko,Ri Masaki,Mizutani Motonori,Goto Mineaki,Gotou Mayuko,Tsunekawa Norikazu,Shikami Masato,Iida Shinsuke,Hosokawa Yoshitaka,Miwa Hiroshi,Ueda Ryuzo,Nitta Masakazu,Takami Akiyoshi
Funder
the Aichi Cancer Research Foundation
the Ministry of Health, Labour and Welfare of Japan
the Ministry of Education, Culture, Sports and Technology of Japan
the SENSHIN Medical Research Foundation
the 24th General Assembly of the Japanese Association of Medical Sciences
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Ludwig H, Sonneveld P, Davies F, Bladé J, Boccadoro M, Cavo M, et al. European perspective on multiple myeloma treatment strategies in 2014. Oncologist. 2014;19:829–44.
2. Watanabe R, Tokuhira M, Kizaki M. Current approaches for the treatment of multiple myeloma. Int J Hematol. 2013;97:333–44.
3. Hata H, Matsuzaki H, Tanaka K, Nomura H, Kagimoto T, Takeya M, et al. Ectopic production of salivary-type amylase by a IgA-lambda-type multiple myeloma. Cancer. 1988;62:1511–5.
4. Matsuzaki H, Takatsuki K. Amylase producing multiple myeloma. Blood. 1989;74:889.
5. Tagawa S, Doi S, Taniwaki M, Abe T, Kanayama Y, Nojima J, et al. Amylase-producing plasmacytoma cell lines, AD3 and FR4, with der(14)t(8;14) and dic(8)t(1;8) established from ascites. Leukemia. 1990;4:600–5.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献